Clinical Trials Directory

Trials / Completed

CompletedNCT00931190

Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia

Evaluation of the Use of Human Papillomavirus Persistence for Determination of the Treatment Efficacy Among Women With Cervical Intraepithelial Neoplasia, and for Prediction of Recurrence of Cervical Disease

Status
Completed
Phase
Study type
Observational
Enrollment
195 (actual)
Sponsor
Lund University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

The objectives are to evaluate the effectiveness of treatment of cervical intraepithelial neoplasia (CIN) by loop electrosurgical excision procedure using persistence of human papillomavirus (HPV) as outcome, and to perform a long-term follow-up on the ability of HPV testing, as compared to cytology, to predict recurrence of high-grade CIN.

Detailed description

Cervical samples for human papillomavirus (HPV) DNA analysis and cytological analysis were obtained from women with abnormal smears referred to Umeå university hospital, Sweden, for treatment with conization. These women were scheduled for HPV DNA testing and Pap smears before and 3, 6, 12, 24 and 36 months after treatment. The HPV DNA testing was performed with a PCR-based genotyping method.

Conditions

Timeline

Start date
2001-02-01
Completion
2005-11-01
First posted
2009-07-02
Last updated
2009-09-15

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT00931190. Inclusion in this directory is not an endorsement.